Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Brownstein, L.
Right arrow Articles by Berry, C. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brownstein, L.
Right arrow Articles by Berry, C. M
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A case report of mitral valve replacement in a patient with lupus antibody syndrome

Louis Brownstein

United Medical Center, Cheyenne, WY, USA, IAABV{at}aol.com

Terry P Bartholomew

United Medical Center, Cheyenne, WY, USA

David G Silver

United Medical Center, Cheyenne, WY, USA

Charles M Berry

United Medical Center, Cheyenne, WY, USA

Systemic lupus erythematosis (SLE) is an autoimmune disease frequently accompanied by the presence of an antiphospholipid antibody (APA). Early referred to as the lupus anticoagulant (LAC), this APA consists of immunoglobulins that are known to interfere with coagulation tests that are phospholipid dependent. Such tests include the partial thromboplastin time (PTT), the activated clotting time (ACT) and may affect the thrombin time (TT). This challenges the cardiac surgical team and the perfusionist responsible for monitoring anticoagulation while performing cardiopulmonary bypass (CPB). A 46- year-old female with a history of SLE, severe mitral insufficiency, an anterior wall myocardial infarction, and the presence of a LAC was admitted for mitral valve surgery. Replacement of the mitral valve was accomplished successfully, utilizing CPB. Anticoagulation was managed using the Hepcon® HMS PLUS, a device that calculates an individual’s heparin dose response and permits assessment of the heparin concentration throughout the procedure. The patient recovered and was sent home 16 days after surgery.

Perfusion, Vol. 18, No. 6, 373-376 (2003)
DOI: 10.1191/0267659103pf689oa
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Gorki, V. Malinovski, and R. D.L. Stanbridge
The antiphospholipid syndrome and heart valve surgery
Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 168 - 181.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
A. H Stammers, R P. Dorion, C. Trowbridge, B. Yen, M. Klayman, J. D Murdock, E. Woods, and C. Gilbert
Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report
Perfusion, March 1, 2005; 20(2): 115 - 120.
[Abstract] [PDF]